Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to ...

As more health facilities acquire 3-D mammogram technology, providers are seeing an increased detection in noninvasive breast cancer and a sharp reduction in the need for patient recalls. Every woman, ...

MARLBOROUGH, Mass., June 7, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Genius™ 3D Mammography™ exam is now the only mammogram that is FDA-approved as superior to ...

Debt financing committed and regulatory approvals received for Gen-Probe Incorporated (Gen-Probe) acquisition. Hologic's 3D Dimensions Tomosynthesis, 2D Selenia, and 2D Dimensions mammography systems ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, today shared the findings from its inaugural Hologic Global Women’s Health Index, the world’s most ...

BEDFORD, Mass., Oct. 31, 2014 /PRNewswire/ -- Hologic, Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) has released reimbursement rates for screening and diagnostic 3D ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...

Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for ...

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, opened its new Innovation Center today ...